2025-J2098

Memorializing Governor Kathy Hochul to proclaim the month of May 2026, as Hepatitis B Awareness Month in the State of New York

Sponsored By

text

2025-J2098


Senate Resolution No. 2098

BY: Senator WEBB

MEMORIALIZING Governor Kathy Hochul to proclaim
the month of May 2026, as Hepatitis B Awareness
Month in the State of New York

WHEREAS, Hepatitis B is a liver infection caused by the hepatitis B
virus; current incidence estimates indicate that approximately 1.8
million Americans are infected with hepatitis B virus; and

WHEREAS, New York has one of the highest hepatitis B burdens in the
nation, with a 2021 study estimating a prevalence of approximately 0.8%,
ranking third among U.S. states; Queens County bears a disproportionate
share of this burden, with an estimated 42,600 residents living with
hepatitis B, the second-highest total among U.S. counties; and

WHEREAS, Hepatitis B spreads from person to person via contact with
infected blood and/or body fluids; and

WHEREAS, Hepatitis B infection can range from an acute, mild,
short-term illness to a chronic, serious, long-term infection that can
lead to cirrhosis and liver cancer; and

WHEREAS, 85% of infants and 50% of older children and adults with
hepatitis B are asymptomatic and about 1 in 2 people who have hepatitis
B are unaware of their infection status; and

WHEREAS, Infants face an increased hepatitis B exposure risk through
everyday contact and infected family members, and are susceptible to
developing acute and serious health issues if they are infected at birth
or in early childhood; and

WHEREAS, Infants exposed to hepatitis B have a 90% risk of
developing chronic hepatitis B, greatly increasing their risk of
developing serious liver conditions such as liver cancer or cirrhosis in
their lifetime; and

WHEREAS, Treatment reduces the risk of serious conditions such as
liver cancer or cirrhosis, but an estimated up to 75 percent of people
who have hepatitis B in the U.S. and are eligible for treatment are not
prescribed treatment, including 40% of those with advanced liver
disease; and

WHEREAS, To safeguard infant health, in 1991, the Advisory Committee
on Immunization Practices (ACIP) issued its first universal hepatitis B
birth dose recommendation, which led to the implementation of the
universal hepatitis B vaccination program in 1992 in the United States;
and

WHEREAS, Before the universal hepatitis B birth dose recommendation,
around 18,000 children in the United States were infected each year by
hepatitis B virus before their 10th birthday; and

WHEREAS, From 1990 to 2019, the universal hepatitis B birth dose
recommendation led to a 99% decline in reported cases of acute hepatitis

B in children and young adults and averted an estimated 90,100 deaths in
the United States: and

WHEREAS, The ACIP ended this universal hepatitis B birth dose
recommendation in 2025 and now recommends it for infants born to women
who tested positive for the hepatitis B virus or whose status is
unknown, limiting other infants to a recommendation for shared clinical
decision-making; and

WHEREAS, Public health analyses suggest that skipping or delaying
the hepatitis B birth dose could result in thousands of preventable
hepatitis B infections and hundreds of millions in avoidable healthcare
costs in the United States; and

WHEREAS, Amidst these changes, several states have reaffirmed their
support for a universal hepatitis B birth dose; and

WHEREAS, These state level changes are beneficial to the public
health landscape and prosperity of those states; and

WHEREAS, Given existing shortfalls in annual hepatitis B screening
practices, despite a universal hepatitis B screening recommendation for
pregnant women, vaccination remains the safest and most effective way to
proactively safeguard public health and prevent the devastating effects
of hepatitis B infection; and

WHEREAS, Given existing gaps related to linkage to care for people
who have hepatitis B, greater awareness of and access to hepatitis B
screening and treatment options is needed to protect the health and
well-being of individuals across New York; now, therefore, be it

RESOLVED, That this Legislative Body pause in its deliberations to
memorialize Governor Kathy Hochul to proclaim May 2026, as Hepatitis B
Awareness Month in the State of New York, and to urge the citizens of
this great Empire State to learn about the causes, symptoms, diagnoses
and treatments for Hepatitis B; and be it further

RESOLVED, That a copy of this Resolution, suitably engrossed, be
transmitted to The Honorable Kathy Hochul, Governor of the State of New
York.

actions

  • 13 / May / 2026
    • REFERRED TO FINANCE

Resolution Details

Law Section:
Resolutions, Legislative

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.